Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL361940 | 1.00 | CA2 (0.63) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL1798885 | 1.00 | CA2 (0.63) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL23071374 | 1.00 | CA2 (0.63) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL284756 | 0.98 | CA2 (0.65) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL1554383 | 0.91 | CA2 (0.68) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL14359878 | 0.89 | CA2 (0.77) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL27901184 | 0.89 | CA2 (0.77) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL14360381 | 0.89 | CA2 (0.77) | CA2MAPK1GRIK1GRIK2LCK | |
| SCHEMBL10897254 | 0.87 | CA2 (0.81) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL18641746 | 0.86 | GRIK1 (0.58) | CA2MAPK1GRIK1GRIK2LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613646-A | Electrochromic material based on organic framework structure and electrochromic device thereof | 宁波祢若电子科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-5795561-A | TUMOR SPECIFIC; MEDICAL DIAGNOSIS | THE BOARD OF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1998-08-18 | — | — | US | disclosed |
| US-5347030-A | Radioiodinated phospholipid ether analogues and methods of using same | THE BOARD OF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1994-09-13 | — | — | US | disclosed |
| EP-0359197-B1 | ANTIHYPERCHOLESTEROLEMIC 4,5-DIARYL-2-SUBSTITUTED THIOIMIDAZOLES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-12-23 | — | — | EP | disclosed |
| US-5093042-A | Site-specific for liver; diagnosis of metastatic cancer | THE UNIVERSITY OF MICHIGAN (US) | 1992-03-03 | — | — | US | disclosed |
| US-5087721-A | Tumor-specific; for diagnosis and therapy | THE UNIVERSITY OF MICHIGAN (US) | 1992-02-11 | — | — | US | disclosed |
| US-4965391-A | Tumor specific | THE UNIVERSITY OF MICHIGAN (US) | 1990-10-23 | — | — | US | disclosed |
| US-4957729-A | CONTRAST | THE UNIVERSITY OF MICHIGAN (US) | 1990-09-18 | — | — | US | disclosed |
| US-4933157-A | IMAGING AGENTS FOR ADRENAL GLANDS | THE UNIVERSITY OF MICHIGAN (US) | 1990-06-12 | — | — | US | disclosed |
| EP-0359197-A1 | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1990-03-21 | — | — | EP | disclosed |
| US-4900744-A | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-02-13 | — | — | US | disclosed |
| US-4873075-A | SITE-SPECIFIC TO LIVER AND HEPATOCYTE; SCINTIGRAPHY IMAGING | THE UNIVERSITY OF MICHIGAN (US) | 1989-10-10 | — | — | US | disclosed |